ECS Botanics Holdings Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ECS Botanics Holdings Ltd with three other
pharmaceutical manufacturers in Australasia:
Regeneus Ltd
(2019
sales of 25,077.00 Australian Dollars [US$17,105.77 ]
),
Genetic Technologies Limited
(25,444.00 Australian Dollars [US$17,356.12 ]
of which 100%
was Operations), and
Prescient Therapeutics Ltd
(72,109.00 Australian Dollars [US$49,187.71 ]
).
Sales Analysis.
Sales fell dramatically in 2019:
ECS Botanics Holdings Ltd reported sales of A$1,384.00 (US$944.07)
for the
fiscal
year ending
June of 2019.
This
represents
a
sharp
decrease of 93.6%
versus 2018, when the company's sales were A$21,643.00 .